DJIA 17,084.81 -1.82 -0.01%
NASDAQ 4,470.47 -3.22 -0.07%
S&P 500 1,989.80 2.79 0.14%
market minute promo

Cytokinetics, Inc. (NASDAQ: CYTK)

4.37 -0.08 (-1.80%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CYTK $4.37 -1.80%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.44
Previous Close $4.45
Daily Range $4.31 - $4.49
52-Week Range $3.96 - $13.38
Market Cap $160.0M
P/E Ratio -4.54
Dividend (Yield) $0.00 (0.0%)
Volume 416,032
Average Daily Volume 587,611
Current FY EPS -$1.21

Sector

Healthcare

Industry

Drugs

Cytokinetics, Inc. (CYTK) Description

A biopharmaceutical company, focused on developing small molecule therapeutics for the treatment of cardiovascular diseases and cancer. Website: http://www.cytokinetics.com/

News & Commentary

3 Stocks That Absolutely Crushed the Market on Friday -- Here's Why athenahealth inc, Puma Biotechno

These health-care stocks have winning written all over them. Here's why athenahealth inc, Puma Biotechnology Inc, and Cytokinetics, Inc. popped on the market today.

Cytokinetics Up on Positive Tirasemtiv Data - Analyst Blog

Sector Update: Healthcare Shares Flat Pre-Market; ImmunoCelluar up 12% on Positive Data on Immunothe

Sector Update: Healthcare Shares Flat Pre-Market; ImmunoCelluar up 12% on Positive Data on Immunotherapeutic Vaccine

Sector Update: Healthcare

Orexigen Will Run: Here's Why

Cytokinetics' (CYTK) CEO Robert Blum Hosts Annual Shareholder Meeting (Transcript)

Short Interest Moves 16% Lower For CYTK

Cytokinetics Still Has Value, Despite Setbacks

Cytokinetics' (CYTK) CEO Robert Blum on Q1 2014 Results - Earnings Call Transcript

ShawCor's CEO Presents at Investor Breakfast and Webcast Following Presentation of Results from BENE

ShawCor's CEO Presents at Investor Breakfast and Webcast Following Presentation of Results from BENEFIT-ALS Conference (Transcript)

Cytokinetics Binary Failure Provides Solid Buying Opportunity

See More CYTK News...

CYTK's Top Competitors

CYTK $4.37 (-1.80%)
Current stock: CYTK
AMGN $122.08 (0.06%)
Current stock: AMGN
GILD $90.82 (0.53%)
Current stock: GILD
BIIB $337.88 (0.08%)
Current stock: BIIB